+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs



Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs



Antiviral Research 109: 54-63



Infection with influenza A virus is still a global concern since it causes significant mortality, morbidity and economic loss. New burst pandemics and rapid emergence of drug-resistance strains in recent years call for novel antiviral therapies. One promising way to overcome this problem is searching new inhibitors among thousands of drugs approved in the clinic for the treatment of different diseases or approved to be safe by clinical trials. In the present work, a collection of 1280 compounds, most of which have been clinically used in human or animal, were screened for anti-influenza activity and 41 hits (SI>4.0) were obtained. Next the 18 hit compounds with SI >10.0 were tested for antiviral activity against 7 other influenza virus strains in canine-originated MDCK cells, 9 compounds exhibited broad antiviral spectrum. The antiviral effects of the 9 compounds were also confirmed in human-originated A549 cells and chicken-originated DF1 cells, by infectious virus yield reduction assay and indirect immunofluorescent assay. Results from the time of addition assay showed that the 9 candidates impaired different stages of influenza virus life cycle, indicating they are novel inhibitors with different mechanisms compared with the existing M2 ion-channel blockers or neuraminidase (NA) inhibitors. Taken together, our findings provide 9 novel drug candidates for the treatment of influenza virus infection. Further mechanism of action study of these inhibitors may lead to the discovery of new anti-influenza targets and structure-activity relationship (SAR) study can be initiated to improve the efficacy of these new classes of influenza inhibitors.

(PDF emailed within 0-6 h: $19.90)

Accession: 055670179

Download citation: RISBibTeXText

PMID: 24971493

DOI: 10.1016/j.antiviral.2014.06.007


Related references

Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening. Antiviral Research 93(1): 48-54, 2012

Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280. Plos One 8(11): E78425-E78425, 2014

Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening. Journal of Virology 90(16): 7368-7387, 2017

Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model. Sar and Qsar in Environmental Research 20(1-2): 103-118, 2009

Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drugs Library. Journal of Virology: -, 2018

Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach. Cell Biochemistry and Biophysics 66(3): 657-669, 2014

High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy. Journal of Biomolecular Screening 17(5): 605-617, 2012

Identification of novel compounds against an R294K substitution of influenza A (H7N9) virus using ensemble based drug virtual screening. International Journal of Medical Sciences 12(2): 163-176, 2015

Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity. Plos One 8(4): E61026-E61026, 2013

The indirect immunofluorescence assay using cardiac tissue from chickens, quails and ducks for identification of influenza A virus during an outbreak of highly pathogenic avian influenza virus (H5N1): a rapid and simple screening tool for limited resource settings. Research in Veterinary Science 83(2): 279-281, 2007

Drug screening for influenza neuraminidase inhibitors. Science in China. Series C, Life Sciences 48(1): 1-5, 2005

Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors. International Journal of Computational Biology and Drug Design 8(1): 1-18, 2015

Drug discovery against H1N1 virus (influenza A virus) via computational virtual screening approach. Medicinal Chemistry Research 20(9): 1445-1449, 2011

Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein. Bmc Complementary and Alternative Medicine 16(1): 519-519, 2017

Development of neuraminidase inhibitors as anti-influenza virus drugs. Drug Development Research 46(3-4): 176-196, March-April, 1999